Hasil Pencarian - Jacques Delaunay
- Menampilkan 1 - 20 hasil dari 24
- Ke Halaman Berikutnya
-
1
-
2
-
3
-
4
Thresholdless behavior and linearity of the optically induced metallization of NbO_{2} oleh J. Kenji Clark, Ya-Lun Ho, Hiroaki Matsui, Hitoshi Tabata, Jean-Jacques Delaunay
Diterbitkan 2019-12-01Dapatkan teks lengkap
Artikel -
5
Combination of an Axicon Fiber Tip and a Camera Device into a Sensitive Refractive Index Sensor oleh Yi-Hsin Tai, Po-Cheng Tsai, Ya-Lun Ho, Jean-Jacques Delaunay, Pei-Kuen Wei
Diterbitkan 2019-11-01Dapatkan teks lengkap
Artikel -
6
Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia oleh Jacques Delaunay, Grzegorz Mazur, Mark Minden, Agnieszka Wierzbowska, Mark M. Jones, Erhan Berrak, Hagop M. Kantarjian
Diterbitkan 2014-01-01Dapatkan teks lengkap
Artikel -
7
Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia oleh Thomas Prebet, Sarah Bertoli, Jacques Delaunay, Arnaud Pigneux, Eric Delabesse, Marie Joelle Mozziconacci, Audrey Bidet, Christian Recher, Norbert Vey
Diterbitkan 2014-10-01Dapatkan teks lengkap
Artikel -
8
Continuous Blood Pressure Monitoring in Daily Life oleh Guillaume LOPEZ, Masaki SHUZO, Hiroyuki USHIDA, Keita HIDAKA, Shintaro YANAGIMOTO, Yasushi IMAI, Akio KOSAKA, Jean-Jacques DELAUNAY, Ichiro YAMADA
Diterbitkan 2010-02-01Dapatkan teks lengkap
Artikel -
9
High-Q lasing via all-dielectric Bloch-surface-wave platform oleh Yang-Chun Lee, Ya-Lun Ho, Bo-Wei Lin, Mu-Hsin Chen, Di Xing, Hirofumi Daiguji, Jean-Jacques Delaunay
Diterbitkan 2023-10-01Dapatkan teks lengkap
Artikel -
10
-
11
A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe... oleh Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, Laurence Legros, Marie Sebert, Thorsten Braun, Jacques Delaunay, Kristell Desseaux, Sylvie Chevret, Pierre Fenaux
Diterbitkan 2019-04-01Dapatkan teks lengkap
Artikel -
12
The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features oleh Marion Eveillard, Jacques Delaunay, Steven Richebourg, Laurence Lodé, Richard Garand, Soraya Wuillème, François Duhoux, Hélène Antoine-Poirel, Catherine Godon, Marie C. Béné
Diterbitkan 2015-03-01Dapatkan teks lengkap
Artikel -
13
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies oleh Claire Oudin, Patrice Chevallier, Sabine Furst, Thierry Guillaume, Jean El Cheikh, Jacques Delaunay, Luca Castagna, Catherine Faucher, Angela Granata, Raynier Devillier, Christian Chabannon, Benjamin Esterni, Norbert Vey, Mohamad Mohty, Didier Blaise
Diterbitkan 2014-11-01Dapatkan teks lengkap
Artikel -
14
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study oleh Patrice Chevallier, Francoise Huguet, Emmanuel Raffoux, Anne Etienne, Thibaut Leguay, Francoise Isnard, Nelly Robillard, Thierry Guillaume, Jacques Delaunay, Aude Charbonnier, Arnaud Pigneux, Pierre Peterlin, Marie C. Bené, William A. Wegener, David M. Goldenberg, Hervé Dombret
Diterbitkan 2015-04-01Dapatkan teks lengkap
Artikel -
15
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial oleh Patrice Chevallier, Myriam Labopin, Gérard Socié, Reza Tabrizi, Sabine Furst, Bruno Lioure, Thierry Guillaume, Jacques Delaunay, Régis Peffault de La Tour, Stéphane Vigouroux, Jean El-Cheikh, Didier Blaise, Mauricette Michallet, Karin Bilger, Noel Milpied, Philippe Moreau, Mohamad Mohty
Diterbitkan 2014-09-01Dapatkan teks lengkap
Artikel -
16
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML oleh Anne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet-Lefebvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive
Diterbitkan 2017-12-01Dapatkan teks lengkap
Artikel -
17
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Franc... oleh Lionel Adès, Fabien Le Bras, Marie Sebert, Charikleia Kelaidi, Thierry Lamy, François Dreyfus, Virginie Eclache, Jacques Delaunay, Didier Bouscary, Sorin Visanica, Pascal Turlure, Agnès Guerci Bresler, Marie-Paule Cabrol, Anne Banos, Michel Blanc, Norbert Vey, Alain Delmer, Eric Wattel, Sylvie Chevret, Pierre Fenaux
Diterbitkan 2012-02-01Dapatkan teks lengkap
Artikel -
18
Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide oleh Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, Marion Eveillard, Yannick Le Bris, Catherine Godon, Olivier Theisen, Anne-Laure Gagez, Guillaume Cartron, Thérèse Commes-Maerten, Bruno Villemagne, Odile Luycx, Pascal Godmer, Catherine Pellat-Deceunynck, Thierry Soussi, Marie C. Béné, Jacques Delaunay, Pierre Peterlin
Diterbitkan 2018-04-01Dapatkan teks lengkap
Artikel -
19
Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies oleh Charikleia Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, Emmanuel Raffoux, Bruno Quesnel, Agnes Guerci, François Dreyfus, Sabine Brechignac, Christian Berthou, Thomas Prebet, Yosr Hicheri, Maya Hacini, Jacques Delaunay, Marie-Pierre Gourin, Jean-Marie Camo, Hacene Zerazhi, Anne-Laure Taksin, Laurence Legros, Bachra Choufi, Pierre Fenaux
Diterbitkan 2010-06-01Dapatkan teks lengkap
Artikel -
20
Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter... oleh Sarah Bertoli, Pierre Bories, Marie C. Béné, Sylvie Daliphard, Bruno Lioure, Arnaud Pigneux, Norbert Vey, Jacques Delaunay, Vincent Leymarie, Isabelle Luquet, Odile Blanchet, Pascale Cornillet-Lefebvre, Mathilde Hunault, Didier Bouscary, Nathalie Fegueux, Philippe Guardiola, François Dreyfus, Jean Luc Harousseau, Jean Yves Cahn, Norbert Ifrah, Christian Récher
Diterbitkan 2014-01-01Dapatkan teks lengkap
Artikel